Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study | Zendy

Bruna Zavarize Reis | Zendy; Alan Lins Fernandes | Zendy; Lucas Peixoto Sales | Zendy; Mayara D Santos | Zendy; Caroline Carvalho dos Santos | Zendy; Ana Jéssica Pinto | Zendy; Karla Fabiana Goessler | Zendy; André Silva Franco | Zendy; Camila SC Duran | Zendy; Carla B. R. Silva | Zendy; Marina Barguil Macêdo | Zendy; Henrique HH Dalmolin | Zendy; Janaína Baggio | Zendy; Guilherme G. M. Balbi | Zendy; Leila Antonângelo | Zendy; Valéria F. Caparbo | Zendy; Bruno Gualano | Zendy; Igor Hisashi Murai | Zendy; Rosa Maria Rodrigues Pereira | Zendy

Open Access

Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study

Author(s) -

Bruna Zavarize Reis,

Alan Lins Fernandes,

Lucas Peixoto Sales,

Mayara D Santos,

Caroline Carvalho dos Santos,

Ana Jéssica Pinto,

Karla Fabiana Goessler,

André Silva Franco,

Camila SC Duran,

Carla B. R. Silva,

Marina Barguil Macêdo,

Henrique HH Dalmolin,

Janaína Baggio,

Guilherme G. M. Balbi,

Leila Antonângelo,

Valéria F. Caparbo,

Bruno Gualano,

Igor Hisashi Murai,

Rosa Maria Rodrigues Pereira

Publication year - 2021

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.608

H-Index - 336

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.1093/ajcn/nqab151

Subject(s) - covid-19 , medicine , prospective cohort study , cohort study , cohort , multicenter study , vitamin d and neurology , university hospital , pediatrics , intensive care medicine , disease , virology , outbreak , infectious disease (medical specialty) , randomized controlled trial

Vitamin D acts as a mediator in the immune system regulating antiviral mechanisms and inflammatory processes. Vitamin D insufficiency has been suggested as a potential risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, although its impact on the prognosis of hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research